Glycoprotein NMB mediates bidirectional GSC-TAM interactions to promote tumor progression

  • JCI Insight. 2025 Jul 8;10(13):e187684. doi: 10.1172/jci.insight.187684.
Yang Liu  1  2 Lizhi Pang  1  2 Fatima Khan  1  2 Junyan Wu  2 Fei Zhou  1  2 Craig Horbinski  2 Shideng Bao  1  3 Jennifer S Yu  1  3 Justin D Lathia  3  4 Peiwen Chen  1  2  3
Affiliations
  • 1. Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • 2. Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • 3. Case Comprehensive Cancer Center, Cleveland, Ohio, USA.
  • 4. Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Abstract

Glioblastoma (GBM) is a lethal brain tumor containing a subpopulation of GBM stem cells (GSCs) that interaction with surrounding cells, including infiltrating tumor-associated macrophages and microglia (TAMs). While GSCs and TAMs are in close proximity and likely interact to coordinate tumor growth, a limited number of mechanisms have been identified that support their communication. Here, we identified glycoprotein NMB (GPNMB) as a key factor mediating a unique bidirectional interaction between GSCs and TAMs in GBM. Specifically, GSCs educated macrophages and microglia to preferentially express GPNMB in the GBM tumor microenvironment. As a result, TAM-secreted GPNMB interacted with its receptor CD44 on GSCs to promote their glycolytic and self-renewal abilities via activating the Pyk2/RSK2 signaling axis. Disrupting GPNMB-mediated GSC-TAM interplay suppressed tumor progression and self-renewal in GBM mouse models. Our study found a protumor function of GPNMB-mediated GSC-TAM bidirectional communication and supports GPNMB as a promising therapeutic target for GBM.

Keywords
Brain cancer; Immunology; Oncology.
Products